V012-2554 Screening compound: 2-{[(2-methylphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole

V012-2554 Screening compound: 2-{[(2-methylphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole
V012-2554 Screening compound: 2-{[(2-methylphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-2554
2-{[(2-methylphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-2554

Molecular Formula

C26H34N4O4S2 (C26 H34 N4 O4 S2)

Compound Name

2-{[(2-methylphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole

IUPAC name

2-{[(2-methylphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-13-benzodiazole

SMILES

Cc1c(CSc2nc(cc(cc3)S(N4CCOCC4)(=O)=O)c3n2CCCN2CCOCC2)cccc1

InChI

InChI=1S/C26H34N4O4S2/c1-21-5-2-3-6-22(21)20-35-26-27-24-19-23(36(31,32)29-13-17-34-18-14-29)7-8-25(24)30(26)10-4-9-28-11-15-33-16-12-28/h2-3,5-8,19H,4,9-18,20H2,1H3

InChI Key

IBDATHNVCWJTFV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19958340

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

530.71

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.067

Distribution Coefficient, logD

3.922

Water Solubility, LogSw

-3.98

Polar Surface Area

61.966

Acid Dissociation Constant (pKa)

24.27

Base Dissociation Constant (pKb)

7.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

V012-2554 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V012-2554 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-2554?
Check Price and Availability of V012-2554, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-2554 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-2554
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-2554
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-2554 available by request